Skip to main navigation
Skip to search
Skip to main content
UT MD Anderson Cancer Center Home
Help & FAQ
Link opens in a new tab
Search content at UT MD Anderson Cancer Center
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Anti-GM-CSF autoantibodies in myeloid leukemias
Anna Sergeeva
,
Wingchi K. Leung
, Lisa St John
,
Jeffrey J. Molldrem
Hematopoietic Biology & Malignancy
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Anti-GM-CSF autoantibodies in myeloid leukemias'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Granulocyte Colony-stimulating Factor (G-CSF)
100%
Myeloid Leukemia
100%
Granulocyte-macrophage Colony-stimulating Factor Autoantibodies
100%
Recombinant Human
28%
Human GM-CSF
28%
Risk Reduction
14%
Disease Progression
14%
Therapeutic Implications
14%
Macrophages
14%
Tumor Site
14%
High-dose Chemotherapy
14%
Therapeutic Vaccine
14%
Immune Cells
14%
Neutrophils
14%
Rare Diseases
14%
Active Disease
14%
High-dose Irradiation
14%
Myeloid Lineage
14%
Hematopoietic Cell Transplantation
14%
Severe Infection
14%
Dendritic Cell Activation
14%
Aβ Production
14%
Autoimmune Pulmonary Alveolar Proteinosis
14%
Immunology and Microbiology
Myeloid
100%
Autoantibody
100%
Granulocyte Macrophage Colony-Stimulating Factor
100%
Drug Megadose
18%
Hematopoietic Cell
9%
Cytokine
9%
Immunocompetent Cell
9%
Lineage
9%
Macrophage
9%
Tumor Vaccine
9%
Cell Transplantation
9%
Dendritic Cell
9%
Neutrophil
9%
Infectious Disease
9%
Autoimmunity
9%
Pulmonary Alveolar Proteinosis
9%
Synthetic Vaccine
9%
Infection
9%